CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity

Liver diseases are one of the leading causes of mortality in the world, mainly caused by different etiological agents, alcohol consumption, viruses, drug intoxication, and malnutrition. The maturation of gene therapy has heralded new avenues for developing effective interventions for these diseases....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Biol Sci
Autores principales: Xu, Tao, Li, Li, Liu, Yu-chen, Cao, Wei, Chen, Jia-si, Hu, Shuang, Liu, Ying, Li, Liang-yun, Zhou, Hong, Meng, Xiao-ming, Huang, Cheng, Zhang, Lei, Li, Jun, Zhou, Huan
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378651/
https://ncbi.nlm.nih.gov/pubmed/32760197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.33481
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares